Evaluation of a PCM Mattress to Treat HIE Infants During Transport

NAActive, not recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2024

Study Completion Date

March 1, 2025

Conditions
Newborn Hypoxic-Ischemic Encephalopathy
Interventions
DEVICE

The NeoHilda Point of care method

This is a procedure that measures Lactate dehydrogenase in a fast and reliable way from only 10 microliter of blood. Using a small point of care card and a Smartphone for analysis.

PROCEDURE

Traditional evaluation

Traditional way of evaluation

Trial Locations (1)

18/879

Neonatal unit, National hospital of Pedriatrics, Hanoi

All Listed Sponsors
collaborator

National Children's Hospital, Vietnam

OTHER

collaborator

Calmark Sweden AB

UNKNOWN

lead

Karolinska Institutet

OTHER

NCT05361473 - Evaluation of a PCM Mattress to Treat HIE Infants During Transport | Biotech Hunter | Biotech Hunter